The Center for Neurocsciences has access to several clinical trials in the treatment of primary brain tumors. Recently, the Center for Neurosciences initiated a Phase II study to determine the safety and efficacy of bevacizumab (Avastin®) plus bi-weekly temozolomide (Temodar®) in the treatment of glioblastoma. The study is currently enrolling patients.

Learn More